Hypertension is highly prevalent after the age of 65 years affecting more than 60% of
individuals in developed countries. Today, there is sufficient evidence from clinical trials that …

Objective Medication non-adherence is a well-recognised issue in chronic diseases but data
in patients with chronic kidney disease (CKD) not receiving kidney replacement therapy …

Importance Medication nonadherence is common among patients with heart failure with
reduced ejection fraction (HFrEF) and can lead to increased hospitalization and mortality …

Lack of medication adherence among patients with dyslipidemia negatively affects health-
related outcomes. This study aims to evaluate medication adherence; we also aim to …

Much is known about the adverse impacts on diabetes outcomes of non-adherence to
diabetes medication. Less is known about how adherence to diabetes medication varies …

Background Adherence to medication is an essential factor in controlling and reducing the
side effects of non-communicable diseases, particularly hypertension. Medication …

Background Although cardiovascular morbidity and mortality are substantial in patients with
chronic kidney disease (CKD), guideline-directed treatment of cardiovascular risk factors …

Adherence to antihypertensives is crucial for control of blood pressure. This study analyzed
factors and interventions that could affect adherence to antihypertensives in the US …

Background: Clinical guidelines recommend beta-blockers, angiotensin-converting enzyme
inhibitors/angiotensin-receptor blockers, and statins for the secondary prevention of acute …

The novel coronavirus SARS-CoV-2 uses the angiotensin-converting enzyme 2 receptor as
an entry point to the cell. Cardiovascular disease (CVD) is a risk factor for COVID-19 with …